Paroxysmal Nocturnal Hemoglobinuria (PNH)
Also known as: Paroxysmal Nocturnal Hemoglobinuria / Paroxysmal nocturnal hemoglobinuria [Marchiafava-Micheli] / Paroxysmal nocturnal haemoglobinuria / Paroxysmal nocturnal hemoglobinuria (disorder)
Drug | Drug Name | Drug Description |
---|---|---|
DB16128 | Crovalimab | A complement C5 inhibiting antibody used to treat paroxysmal nocturnal hemoglobinuria in adults and adolescents. |
DB01257 | Eculizumab | A recombinant humanized monoclonal antibody used to reduce the risk of hemolysis in paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS). |
DB11580 | Ravulizumab | A monoclonal antibody used to treat paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, and myasthenia gravis. |
Drug | Drug Name | Target | Type |
---|---|---|---|
DB16128 | Crovalimab | Complement C5 | target |
DB01257 | Eculizumab | Complement C5 | target |
DB11580 | Ravulizumab | Complement C5 | target |